FDA approved vs. Pharmacy compounded 17-OHPC-current issues for obstetricians to consider in reducing recurrent preterm birth.

Autor: Gandell DL; Department of Obstetrics and Gynecology, University of Rochester Medical Center, Rochester, NY, USA., Randell MD; OBGYN Atlanta, Emory Saint Joseph's Hospital, Atlanta, GA, USA., Gudeman JL; AMAG Pharmaceuticals, Waltham, MA, USA.

Publikováno v: Current medical research and opinion [Curr Med Res Opin] 2020 Aug; Vol. 36 (8), pp. 1393-1401. Date of Electronic Publication: 2020 Jun 30.